1. A novel pathway activated by somatostatin receptor type 2 (SST2): Inhibition of pituitary tumor cell migration and invasion through cytoskeleton protein recruitment. Issue 9 (20th December 2017) Authors: Peverelli, E.; Giardino, E.; Treppiedi, D.; Catalano, R.; Mangili, F.; Locatelli, M.; Lania, A.G.; Arosio, M.; Spada, A.; Mantovani, G. Journal: International journal of cancer Issue: Volume 142:Issue 9(2018) Page Start: 1842 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CAMP/PKA-induced filamin A (FLNA) phosphorylation inhibits SST2 signal transduction in GH-secreting pituitary tumor cells. (28th October 2018) Authors: Peverelli, E.; Giardino, E.; Mangili, F.; Treppiedi, D.; Catalano, R.; Ferrante, E.; Sala, E.; Locatelli, M.; Lania, A.G.; Arosio, M.; Spada, A.; Mantovani, G. Journal: Cancer letters Issue: Volume 435(2018) Page Start: 101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cofilin is a mediator of RET-promoted medullary thyroid carcinoma cell migration, invasion and proliferation. (15th September 2019) Authors: Giardino, E.; Catalano, R.; Barbieri, A.M.; Treppiedi, D.; Mangili, F.; Spada, A.; Arosio, M.; Mantovani, G.; Peverelli, E. Journal: Molecular and cellular endocrinology Issue: Volume 495(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Octreotide and pasireotide effects on medullary thyroid carcinoma (MTC) cells growth, migration and invasion. (15th January 2021) Authors: Giardino, E.; Catalano, R.; Mangili, F.; Barbieri, A.M.; Treppiedi, D.; Elli, F.M.; Dolci, A.; Contarino, A.; Spada, A.; Arosio, M.; Mantovani, G.; Peverelli, E. Journal: Molecular and cellular endocrinology Issue: Volume 520(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The cytoskeleton actin binding protein filamin A impairs both IGF2 mitogenic effects and the efficacy of IGF1R inhibitors in adrenocortical cancer cells. (28th January 2021) Authors: Catalano, R.; Giardino, E.; Treppiedi, D.; Mangili, F.; Morelli, V.; Elli, F.M.; Serban, A.L.; Luconi, M.; Mannelli, M.; Spada, A.; Arosio, M.; Mantovani, G.; Peverelli, E. Journal: Cancer letters Issue: Volume 497(2021) Page Start: 77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗